Literature DB >> 15136164

Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS.

Raphaele Gerber1, Jessica D Ryan, Douglas S Clark.   

Abstract

We present an integrated consolidation of previously reported methods for screening hydroxymethylglutaryl-coenzyme A reductase (HMGR) inhibitors in 96-well microtiter plates with rapid workup using established mammalian cell lines and liquid chromatography-mass spectrometry analysis. Inhibitors as well as expression regulators of HMGR (inducers or repressors) can be screened. To validate the method, three competitive inhibitors of HMGR (lovastatin, simvastatin, and atorvastatin), as well as a potent sterol repressor of HMGR synthesis (25-hydroxycholesterol), were assayed on two cell lines: HepG2, a human hepatic derived cell line, and L cells, a subline of NCTC clone 929 mouse fibroblasts. The direct inhibition of HMGR by statins, induction of HMGR synthesis by the same statins following incubation with the cells, and repression of HMGR synthesis by 25-hydroxycholesterol were confirmed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136164     DOI: 10.1016/j.ab.2004.03.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Modulation of lipid metabolism by deep-sea water in cultured human liver (HepG2) cells.

Authors:  Shan He; Jiejie Hao; Weibing Peng; Peiju Qiu; Chunxia Li; Huashi Guan
Journal:  Mar Biotechnol (NY)       Date:  2013-09-24       Impact factor: 3.619

2.  Effects of atorvastatin on time-dependent change of fast sodium current in simulated acute ischaemic ventricular myocytes.

Authors:  Hongshi Li; Zheng Wan; Xiaolong Li; Tianming Teng; Xin Du; Jing Nie
Journal:  Cardiovasc J Afr       Date:  2019-07-29       Impact factor: 1.167

3.  The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.

Authors:  Agata Maciejak; Agata Leszczynska; Ilona Warchol; Monika Gora; Joanna Kaminska; Danuta Plochocka; Monika Wysocka-Kapcinska; Dorota Tulacz; Joanna Siedlecka; Ewa Swiezewska; Maciej Sojka; Witold Danikiewicz; Norbert Odolczyk; Anna Szkopinska; Grazyna Sygitowicz; Beata Burzynska
Journal:  BMC Biotechnol       Date:  2013-08-30       Impact factor: 2.563

4.  RNA-sequencing analysis of HepG2 cells treated with atorvastatin.

Authors:  Camilla Stormo; Marianne K Kringen; Robert Lyle; Ole Kristoffer Olstad; Daniel Sachse; Jens P Berg; Armin P Piehler
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

5.  Current literature in mass spectrometry.

Authors: 
Journal:  J Mass Spectrom       Date:  2004-11       Impact factor: 1.982

6.  Investigating the effects of statins on cellular lipid metabolism using a yeast expression system.

Authors:  Agata Leszczynska; Beata Burzynska; Danuta Plochocka; Joanna Kaminska; Magdalena Zimnicka; Magdalena Kania; Marek Kiliszek; Monika Wysocka-Kapcinska; Witold Danikiewicz; Anna Szkopinska
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.